Scoping Review of Economic Analyses of Rare Kidney Diseases
Introduction: Rare kidney diseases (RKDs) place a substantial economic burden on patients and health systems, the extent of which is unknown and may be systematically underestimated by health economic techniques. We aimed to investigate the economic burden and cost-effectiveness evidence base for RK...
Saved in:
| Main Authors: | Blake Angell, Siyuan Wang, Thomas Gadsden, Monica Moorthy, Charu Malik, Jonathan Barratt, Olivier Devuyst, Ifeoma I. Ulasi, Daniel P. Gale, Agnivo Sengupta, Anna Palagyi, Vivekanand Jha, Stephen Jan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Kidney International Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924019223 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic Scoping Review of Socioeconomic Burden and Associated Psychosocial Impact in Patients With Rare Kidney Diseases and Their Caregivers
by: Anna Palagyi, et al.
Published: (2025-03-01) -
Early Intervention, Big Savings: The Future of CKD Management in Thailand
by: Blake Angell, et al.
Published: (2024-08-01) -
Impact on the family of a child’s rare disease: A large cross-sectional study
by: Judith M. Jobling, et al.
Published: (2025-01-01) -
Incidence and health burden of 20 rare neurological diseases in South China from 2016 to 2022: a hospital-based observational study
by: Jingjing Li, et al.
Published: (2025-04-01) -
Clinical features, disease burden and impact on quality of life in participants with mitochondrial encephalomyopathy
by: John Sieh Dumbuya, et al.
Published: (2025-07-01)